Search

Simulations Plus Inc

Suletud

SektorTervishoid

18.42 -0.05

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

18.42

Max

18.44

Põhinäitajad

By Trading Economics

Sissetulek

-960K

3.6M

Müük

-2.4M

22M

P/E

Sektori keskmine

46.05

56.432

Aktsiakasum

0.3

Kasumimarginaal

16.335

Töötajad

212

EBITDA

-6.3M

1.1M

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

-13.23% downside

Turustatistika

By TradingEconomics

Turukapital

1.4M

373M

Eelmine avamishind

18.47

Eelmine sulgemishind

18.42

Uudiste sentiment

By Acuity

50%

50%

111 / 339 Pingereas Healthcare

Simulations Plus Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

21. sept 2026, 23:52 UTC

News

Boeing Co. has secured two defense contracts worth $41.5 million, while shares have declined slightly in after-market trading, remaining near the lower end of their one-month range.

21. sept 2026, 23:51 UTC

News

BlackRock Inc. is trading modestly lower in after-market hours, following the launch of its customizable LifePath Solutions target date framework.

21. sept 2026, 23:50 UTC

News

Northrop Grumman Corp is trading modestly lower in after-market hours, retracing from a peak and positioned below its 20-day moving average.

21. sept 2026, 23:36 UTC

Correlated Moves
News

The USD/DKK is trading higher as the People's Bank of China maintained its one-year Loan Prime Rate at 3.00%, signaling stable monetary policy.

21. sept 2026, 23:31 UTC

News

Tapestry Inc is trading modestly higher in after-market hours, with a current market capitalization of $22.56 billion, following three consecutive lower closes.

21. sept 2026, 23:25 UTC

News

Pentair PLC declared a $0.27 quarterly dividend amid a class action lawsuit alleging securities fraud, with shares modestly lower in after-market trading.

21. sept 2026, 23:15 UTC

News

TransDigm Group Inc. announced its Extant Aerospace unit will acquire assets for approximately $240 million, driving the stock higher in after-market hours.

21. sept 2026, 23:15 UTC

News

Baidu Inc faces two class action lawsuits alleging securities fraud, contributing to a slight decline in after-market trading amid ongoing financial concerns.

21. sept 2026, 23:11 UTC

Social Media
News

Eli Lilly has started construction on a $6.5 billion facility in Houston to produce its GLP-1 receptor agonist, Foundayo, creating over 600 permanent jobs.

21. sept 2026, 23:11 UTC

Social Media
News

Intel Corp shares advanced during after-market hours, supported by a record-high Nasdaq close and favorable conditions from falling Treasury yields and oil prices.

21. sept 2026, 23:06 UTC

News

Weyerhaeuser Co announced a $1 million investment in Drayton Valley, Alberta, marking its first Thrive program initiative in Canada, with shares modestly higher in after-market trading.

21. sept 2026, 23:06 UTC

News
Correlated Moves

Coinbase Global Inc is launching an IPO allocation service for U.S. customers and ceasing sports wagering in Michigan, with shares trading higher in after-market hours.

21. sept 2026, 23:06 UTC

News

Ethereum's price has advanced sharply to $2.67K, supported by a broader cryptocurrency rally and increased interest from large holders amid positive regulatory developments.

21. sept 2026, 23:06 UTC

News

Ethereum's price has advanced sharply to $2.67K, supported by regulatory developments and increased interest from large holders amid a broader cryptocurrency rally.

21. sept 2026, 23:05 UTC

News

Biogen Inc. is trading slightly higher in after-market hours following approvals for at-home LEQEMBI in Japan and China and new Phase 3 data for EMPAVELI.

21. sept 2026, 23:02 UTC

News
Social Media

GameStop shares rose in after-hours trading as CEO Ryan Cohen disclosed the purchase of 1.15M shares for about $26.4 million, increasing his ownership to 40.5 million.

21. sept 2026, 23:02 UTC

News

Bitcoin is sharply higher today, reaching its highest level since January, amid a broader cryptocurrency rally and positive U.S.-China trade developments.

21. sept 2026, 23:02 UTC

News

Bitcoin surged today to its highest level since January, driven by positive U.S.-China trade developments and easing inflation concerns, despite an earlier pullback.

21. sept 2026, 23:01 UTC

News

Decline in after-market trading after CMS announces potential fee cuts.

21. sept 2026, 23:01 UTC

News

Thor Industries shares rose in after-market trading following Keystone RV's record sales at the Hershey RV Show, attributed to strong dealer preparation and customer interest.

21. sept 2026, 23:01 UTC

News

Salesforce Inc shares are advancing in after-market trading following director David Kirk's acquisition of 4.18k shares for approximately $999.5k.

21. sept 2026, 23:01 UTC

News
Social Media

Vicor Corporation raised its Q3 2026 growth guidance from nearly 10% to over 20%, driving a sharp rise in its share price during after-hours trading.

21. sept 2026, 23:01 UTC

News

General Motors Co's stock is higher in after-market trading following a $697.7 million contract modification awarded to GM Defense LLC by the U.S. Department of War.

21. sept 2026, 23:01 UTC

News

DICK'S Sporting Goods Inc faces class action lawsuits over alleged securities fraud, contributing to a modest decline in after-market trading following disappointing earnings.

21. sept 2026, 23:01 UTC

Macro News
Correlated Moves
News

The U.S. dollar is consolidating against the yen, currently around JPY156.50, with options worth $2.3 billion expiring today.

21. sept 2026, 23:00 UTC

News

Endava PLC's shares have declined sharply in after-market trading following the appointment of Conor McShane as Interim CFO amid an accounting investigation.

21. sept 2026, 22:51 UTC

News
Social Media

Robinhood Markets Inc's stock is trading lower after-hours, reversing from a high of $126.41 earlier in the session amid a recovering cryptocurrency market.

21. sept 2026, 22:01 UTC

News

In after-market trading, Gartner Inc. has moved higher following five consecutive lower daily closes, despite remaining below its 20-day moving average.

21. sept 2026, 21:01 UTC

News
Event

AnaptysBio reported Q2 net income of $183.88 million and EPS of $5.11, exceeding expectations, leading to a rise in after-market trading.

21. sept 2026, 20:12 UTC

News
Correlated Moves

NBT Bancorp Inc. is trading higher in after-market hours following the announcement of Kimberly A. Boynton's appointment to its Board of Directors, effective October 1, 2026.

Võrdlus sarnastega

Hinnamuutus

Simulations Plus Inc Prognoos

Hinnasiht

By TipRanks

-13.23% langus

12 kuu keskmine prognoos

Keskmine 16 USD  -13.23%

Kõrge 16 USD

Madal 16 USD

Põhineb 2 Wall Streeti analüütiku instrumendi Simulations Plus Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

2 ratings

0

Osta

2

Hoia

0

Müü

Sentiment

By Acuity

111 / 339 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.